… This intercalated therapy avoided the G1 arrest by erlotinib, thus optimizing the cell-cycle …
In this meta-analysis, continuous erlotinib plus chemotherapy versus chemotherapy alone …

… and safety of erlotinib and bevacizumab for NSCLC, we conducted a meta-analysis and …
for combination therapy of bevacizumab plus erlotinib with bevacizumab or erlotinib alone. …

… meta-analysis to assess the potential of erlotinib plus platinum-based chemotherapy relative
to platinum-based chemotherapy alone … for studies regarding erlotinib plus platinum-based …

… landscape of the first-line drug erlotinib and detail the selection of mAbs … meta-analysis to
elucidate the efficacy and safety of erlotinib combined with mAbs compared with erlotinib alone …

… erlotinib in combination with bevacizumab compared with single agents remain unclear. This
meta-analysis … were eligible for meta-analysis, the results of which suggested erlotinib with …

… Our meta-analysis provided evidence that the erlotinib plus … with erlotinib alone; therefore,
in the clinic, when erlotinib monotherapy is ineffective, the addition of bevacizumab to erlotinib …

… The results of this meta-analysis showed that the anti-VEGF + erlotinib combination
significantly prolonged PFS compared to erlotinib monotherapy in patients with EGFR-mutated …

… arm alone, in cases for which there was no control arm, or compared with a control arm.
Only entries with data in both control and experimental arms were used in meta-analyses. If …

… in this meta-analysis. The combination of bevacizumab and erlotinib significantly improved
… of NSCLC compared with bevacizumab or erlotinib alone. However, no significant difference …

… Six trials were included in analyzing bevacizumab and erlotinib in EGFRm metastatic … result
of the meta-analysis and the forest plot analysis showed that the bevacizumab and erlotinib …